Cardio Diagnostics Holdings (NASDAQ: CDIO) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Cardio Diagnostics Holdings earnings for the quarter were -$1.39 million. In the same quarter last year, Cardio Diagnostics Holdings's earnings per share (EPS) was -$1.09.
As of Q2 2024, Cardio Diagnostics Holdings's earnings has grown year over year. Cardio Diagnostics Holdings's earnings in the past year totalled -$8.38 million.
What was CDIO's revenue last quarter?
Cardio Diagnostics Holdings (NASDAQ: CDIO) reported Q4 2023 revenue of $5.31 thousand up 458.95% year over year. In the same quarter last year, Cardio Diagnostics Holdings's revenue was $950.00.
What was CDIO's revenue growth in the past year?
As of Q2 2024, Cardio Diagnostics Holdings's revenue has grown 1,696.32% year over year. This is 1,547.91 percentage points higher than the US Biotechnology industry revenue growth rate of 148.4%. Cardio Diagnostics Holdings's revenue in the past year totalled $17.07 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.